Clinical ResearchInterventional CardiologyEverolimus-Eluting Versus Sirolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: The EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) Randomized Trial
Interventional Cardiology
Under an Elsevier user license
open archive
Key Words
everolimus
percutaneous coronary intervention
sirolimus
stents
Abbreviations and Acronyms
CI
confidence interval
DES
drug-eluting stent(s)
EES
everolimus-eluting stent(s)
LL
late loss
MI
myocardial infarction
MLD
minimal luminal diameter
PCI
percutaneous coronary intervention
PES
paclitaxel-eluting stent(s)
QCA
quantitative coronary angiography
RR
relative risk
SES
sirolimus-eluting stent(s)
TLF
target lesion failure
TLR
target lesion revascularization
Cited by (0)
This study was supported by a grant from the Clinical Research Center for Ischemic Heart Disease, Seoul, Republic of Korea (0412-CR02-0704-0001), and a grant from the Innovative Research Institute for Cell Therapy, Seoul National University Hospital (A062260), sponsored by the Ministry of Health, Welfare & Family, Republic of Korea. The authors also received unrestricted grants from Abbott Vascular Korea and Boston Scientific Korea. The funding source of the study had no role in study design, data collection, monitoring, analysis, interpretation, or writing of the manuscript. The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Copyright © 2011 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.